From: Tracking of stem cells in vivo for cardiovascular applications
Physical principle | Modality | Cell labels | Advantages | Disadvantages | |
---|---|---|---|---|---|
Tissue contrast based | Magnetic field change | CMR | • Iron oxides | • High spatial resolution | • Low sensitivity |
• Gad-chelates | • Signal not linked to cell viability | ||||
• Microcapsules | • High anatomic detail | ||||
• Reporter genes (enzyme-based, transporter-based) | • Lack of CMR-compatible devices for interactivity | ||||
• No ionizing radiation | |||||
• Post-processing capabilities | |||||
• Not compatible for patients with implants | |||||
• Permits medium-term tracking | |||||
• Expensive | |||||
• Acoustic noise | |||||
Electron density change | X-Ray/CT | • Gold Nanoparticles | • High sensitivity | • Ionizing radiation | |
• Microcapsules | • High potential of real-time interactivity | • Limited spatial resolution | |||
• Lacks soft tissue detail | |||||
Echogenicity change | US | • Liposomes | • High potential of real-time interactivity | • Difficultly with thin/obese patients | |
• Microbubbles | |||||
• Microcapsules | • Highly operator dependent | ||||
• Perfluorocarbons | • No ionizing radiation | ||||
• Interpretation has high learning curve | |||||
• Inexpensive | |||||
• Highly portable | |||||
• Limited resolution | |||||
• Acoustic artifacts may compromise image | |||||
Photon emission based | Radionuclide imaging (High energy ionizing radiation) | PET | • Reporter genes, e.g. HSV-tk, hNIS | • High sensitivity | • Poor anatomic detail |
• High translational capacity | |||||
• Poor interactivity | |||||
• Radionuclides, e.g. 18 F-FHBG, 124I FIAU, and 18 F-FDG | • Ionizing radiation | ||||
• Temporal limitations (due to radioactive decay) | |||||
SPECT | • Radionuclides, e.g. 111In oxine, 99mTc and18 F FDG | • Concerns for label-induced cellular toxicity | |||
• Biohazardous labels | |||||
• Expensive | |||||
Optical imaging (Low energy radiation) | BLI | • Reporter genes, e.g. luciferase | • Permits longitudinal monitoring | • Limited spatial resolution | |
• Lacks clinical relevance | |||||
• Low background | |||||
• No excitation light required | • Biohazardous labels | ||||
Fluorescence | • Fluorophores, e.g. GFP | • High sensitivity | • Photon attenuation w/cell division | ||
• Multiplexing | |||||
• Near-infrared probes | • No ionizing radiation | • Autofluorescence yields high background | |||
• Quantum dots | • Low cost | ||||
• Small depth of high-resolution | |||||
• Permits short-term tracking | |||||
• Biohazardous labels |